Skip to main content

KCK Ltd.

SEC CIK
0001657662
Latest filing
Oct 14, 2025

The latest 13F from KCK Ltd. covers Q3 2025 (filed Oct 14, 2025): 2 long positions worth $15.1M. The top 10 holdings make up 100.0% of the portfolio, and the largest is Sight Sciences, Inc. (SGHT) at 99.7%. Livermore has 12 filings on Form 13F from this institution, going back to Q4 2021.

What changed in Q3 2025

Share counts compared with Q2 2025: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
0
Added
0
Reduced
0
Sold out
0

Top 5 holdings

Share of this quarter's portfolio value

  1. SGHTSight Sciences, Inc.
    99.7%$15.0MHistory
  2. RNTXRein Therapeutics, Inc.
    0.3%$52.1KHistory

Biggest buys

New and added positions, by estimated amount bought

None this quarter.

Largest weight increases

New and added positions, by percentage points of the portfolio gained

None this quarter.

Biggest sells

Reduced and sold-out positions, by estimated amount sold

None this quarter.

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

None this quarter.

Metrics

13F metrics for Q3 2025, computed only from the numbers in the filings. Definitions below.

Portfolio value
$15.1M
−$2.97M (−16.4%) vs. prior quarter
Positions
2
0 vs. prior quarter
Top 10 concentration
100.0%
Top 10 as share of value
Turnover
0.0%
Q3 2025, one quarter
Average holding period
4.0 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2021), so positions held before then are understated.

13F filings by quarter

12 quarters, going back to Q4 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $141.6M (Q4 2021)

Q4 2021: $141.6MQ1 2022: $102.5MQ2 2022: $71.2MQ3 2022: $51.6MQ4 2022: $66.7MQ1 2023: $67.3MQ2 2023: $63.8MQ3 2023: $70.4MQ4 2024: $75.0MQ1 2025: $10.5MQ2 2025: $18.1MQ3 2025: $15.1M
Q4 2021Q3 2025
13F filings of KCK Ltd. by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q3 2025Oct 14, 20252$15.1MSGHTRNTXvs. Q2 2025SEC
Q2 2025Jul 8, 20252$18.1MSGHTvs. Q1 2025SEC
Q1 2025Jul 11, 20252$10.5MSGHTRNTXvs. Q4 2024SEC
Q4 2024Jan 15, 20253$75.0MNPCESGHTRNTX–SEC
Q3 2023Nov 1, 20233$70.4MNPCESGHTRNTXvs. Q2 2023SEC
Q2 2023Jul 25, 20233$63.8MSGHTNPCERNTXvs. Q1 2023SEC
Q1 2023May 5, 20233$67.3MSGHTNPCERNTXvs. Q4 2022SEC
Q4 2022Jan 31, 20233$66.7MSGHTNPCERNTXvs. Q3 2022SEC
Q3 2022Oct 31, 20223$51.6MSGHTNPCERNTXvs. Q2 2022SEC
Q2 2022Aug 10, 20224$71.2MSGHTNPCEIMUXvs. Q1 2022SEC
Q1 2022May 11, 20224$102.5MSGHTNPCEIMUXvs. Q4 2021SEC
Q4 2021Feb 11, 20224$141.6MSGHTNPCEIMUX–SEC